Unique ID issued by UMIN | UMIN000047162 |
---|---|
Receipt number | R000053799 |
Scientific Title | Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer |
Date of disclosure of the study information | 2022/05/01 |
Last modified on | 2022/03/13 11:50:54 |
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer
Biomarkers to predict irAEs in patients with NSCLC
Investigation of biomarkers to predict immune-related adverse events in patients with non-small cell lung cancer
Biomarkers to predict irAEs in patients with NSCLC
Japan |
Non-small cell lung cancer
Pneumology |
Malignancy
NO
Investigation for molecular markers that enable the prediction or early detection of immune-related adverse events in the combination of chemotherapy and immunotherapy for non-small cell lung cancer
Others
Exploratory research
Onset of drug-induced interstitial lung disease
Onset of immune-related adverse events
Observational
20 | years-old | <= |
100 | years-old | >= |
Male and Female
1. The age at the time of obtaining consent is 20 years or older.
2. Diagnosed as non-small cell lung cancer.
3. chemo-IO is planned.
4. Expected to survive for more than 6 months after registration.
5. Written consent is obtained.
1. Patients with active double cancer (simultaneous double cancer and metachronous double cancer with no disease period within 3 years).
2. Patients with ILD complications prior to treatment (Intestinal Lung Abnormality (ILA) is acceptable).
3. Patients with autoimmune disease.
4. Patients taking 10 mg or more of prednisolone.
5. Patients who the principal investigator deems inappropriate for this study.
114
1st name | Tatsuya |
Middle name | |
Last name | Nagano |
Kobe University Hospital
Respiratory Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe
0783825660
tnagano@med.kobe-u.ac.jp
1st name | Tatsuya |
Middle name | |
Last name | Nagano |
Kobe University Hospital
Respiratory Medicine
650-0017
7-5-2 Kusunoki-cho, Chuo-ku, Kobe
0783825660
tnagano@med.kobe-u.ac.jp
Kobe University
Self-funding
Self funding
Kobe University Hospital Clinical Translational Research Center
7-5-2 Kusunoki-cho, Chuo-ku, Kobe
0783826669
kansatsu@med.kobe-u.ac.jp
NO
2022 | Year | 05 | Month | 01 | Day |
Unpublished
Preinitiation
2022 | Year | 03 | Month | 13 | Day |
2022 | Year | 05 | Month | 01 | Day |
2023 | Year | 01 | Month | 31 | Day |
Peripheral blood is collected before the start of chemo-IO and after 1 week, 6 weeks, and 21 weeks.
2022 | Year | 03 | Month | 13 | Day |
2022 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000053799
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |